Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization

Lawrence Liao; Christopher H Cabell; James G Jollis; Eric J Velazquez; William T Smith 4th; Kevin J Anstrom; Paul A Pappas; Thomas Ryan; Joseph A Kisslo; Carolyn K Landolfo

doi:10.1016/j.amjcard.2004.01.071

Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization

Am J Cardiol. 2004 May 15;93(10):1275-9. doi: 10.1016/j.amjcard.2004.01.071.

Authors

Lawrence Liao¹, Christopher H Cabell, James G Jollis, Eric J Velazquez, William T Smith 4th, Kevin J Anstrom, Paul A Pappas, Thomas Ryan, Joseph A Kisslo, Carolyn K Landolfo

Affiliation

¹ Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA. [email protected]

PMID: 15135703
DOI: 10.1016/j.amjcard.2004.01.071

Abstract

In 107 patients with coronary disease and severe left ventricular dysfunction, we examined the prognostic power of viability identified by dobutamine stress echocardiography. At a mean follow-up of 27 months, patients with viable myocardium who underwent revascularization had a significant survival advantage over all other patients (2-year survival 83.5% vs 57.2%, p = 0.0037).

Publication types

Evaluation Study

MeSH terms

Angioplasty, Balloon, Coronary
Cardiotonic Agents
Dobutamine
Echocardiography
Exercise Test
Female
Georgia
Humans
Male
Middle Aged
Myocardial Ischemia / complications
Myocardial Ischemia / diagnosis*
Myocardial Ischemia / diagnostic imaging
Myocardial Ischemia / mortality*
Myocardial Ischemia / therapy
Prognosis
Survival Analysis
Ventricular Dysfunction, Left / complications*
Ventricular Dysfunction, Left / physiopathology

Substances

Cardiotonic Agents
Dobutamine